Related references
Note: Only part of the references are listed.Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+T-Cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine
Vivek Shinde et al.
CLINICAL INFECTIOUS DISEASES (2021)
The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable
Susheel K. Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Comparative Genome Analysis of Lactococcus lactis Indicates Niche Adaptation and Resolves Genotype/Phenotype Disparity
Michiel Wels et al.
FRONTIERS IN MICROBIOLOGY (2019)
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
Susheel K. Singh et al.
FRONTIERS IN IMMUNOLOGY (2019)
Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2
Jean Claude Dejon-Agobe et al.
CLINICAL INFECTIOUS DISEASES (2019)
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria
Benjamin Mordmueller et al.
CLINICAL INFECTIOUS DISEASES (2019)
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
Sofia E. Magnusson et al.
IMMUNOLOGIC RESEARCH (2018)
Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum
Susheel K. Singh et al.
MICROBIAL CELL FACTORIES (2018)
Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine
Vivek Shinde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults
Issaka Sagara et al.
LANCET INFECTIOUS DISEASES (2018)
The GMZ2 malaria vaccine: from concept to efficacy in humans
Michael Theisen et al.
EXPERT REVIEW OF VACCINES (2017)
Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine
Michael Theisen et al.
EXPERT REVIEW OF VACCINES (2017)
Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria
Ikhlaq Hussain Kana et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine
Susheel K. Singh et al.
MICROBIAL CELL FACTORIES (2017)
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display
Susheel K. Singh et al.
VACCINE (2017)
Seven-Year Efficacy of RTS, S/AS01 Malaria Vaccine among Young African Children
Ally Olotu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Naturally acquired immunity to sexual stage P. falciparum parasites
Will J. R. Stone et al.
PARASITOLOGY (2016)
Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
Karin Lovgren Bengtsson et al.
VACCINE (2016)
Synthetic TLR4 agonists enhance functional antibodies and CD4+T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen
Susan L. Baldwin et al.
VACCINE (2016)
Safety and Immunogenicityof Pfs25-EPA/Alhydrogel® , a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naive Adults
Kawsar R. Talaat et al.
PLOS ONE (2016)
Genome-Wide Transcriptional Responses to Carbon Starvation in Nongrowing Lactococcus lactis
Onur Ercan et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies
Susheel K. Singh et al.
VACCINE (2015)
Molecular and Metabolic Adaptations of Lactococcus lactis at Near-Zero Growth Rates
Onur Ercan et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
Recombinant protein expression in Lactococcus lactis using the P170 expression system
Casper M. Jorgensen et al.
FEMS MICROBIOLOGY LETTERS (2014)
A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages
Michael Theisen et al.
VACCINE (2014)
Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice
Sofia E. Magnusson et al.
VACCINE (2014)
Matrix-M (TM) adjuvant: enhancing immune responses by 'setting the stage' for the antigen
Karin Lovgren Bengtsson et al.
EXPERT REVIEW OF VACCINES (2013)
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
Sofia E. Magnusson et al.
VACCINE (2013)
Measuring the blockade of malaria transmission - An analysis of the Standard Membrane Feeding Assay
Thomas S. Churcher et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2012)
Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
Jenny M. Reimer et al.
PLOS ONE (2012)
Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
Kazutoyo Miura et al.
PLOS ONE (2011)
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2-A GLURP-MSP3 fusion protein malaria vaccine candidate
Susana Lousada-Dietrich et al.
VACCINE (2011)
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
Bernhards R. Ogutu et al.
PLOS ONE (2009)
Generalized linear mixed models: a practical guide for ecology and evolution
Benjamin M. Bolker et al.
TRENDS IN ECOLOGY & EVOLUTION (2009)
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
Issaka Sagara et al.
VACCINE (2009)
B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node
Yolanda R. Carrasco et al.
IMMUNITY (2007)
Epitope analysis of the malaria surface antigen Pfs48/45 identifies a subdomain that elicits transmission blocking antibodies
Nikolay Outchkourov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Protein secretion in Lactococcus lactis:: an efficient way to increase the overall heterologous protein production -: art. no. 2
Y Le Loir et al.
MICROBIAL CELL FACTORIES (2005)
A Plasmodium falciparum GLURP-MSP3 chimeric protein;: expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies
M Theisen et al.
VACCINE (2004)
Share Paper
